Use Of Microarrays and Epigenetics In Gene Expression Of Uveitis & AMD Patients
微阵列和表观遗传学在葡萄膜炎基因表达中的应用
基本信息
- 批准号:8938308
- 负责人:
- 金额:$ 23.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:Adrenal Cortex HormonesAge related macular degenerationApoptosisAutoimmune ProcessAutoimmune ResponsesBiological MarkersBlindnessCD4 Positive T LymphocytesCellsCharacteristicsDNADiseaseEpigenetic ProcessExposure toEyeGene ExpressionGene Expression RegulationImmuneImmunologic MarkersInflammatoryInflammatory ResponseInterleukin-17LengthLeukocytesMachine LearningMarylandMemoryMolecular ProfilingPathway interactionsPatientsPharmaceutical PreparationsPhenotypeProceduresRNARefractoryRefractory DiseaseReportingSarcoidosisSchemeSerumSignal PathwaySteroidsSubgroupTechniquesTelomere ShorteningTh1 CellsTherapeutic InterventionUniversitiesUveitisactive controlbasedisease phenotypeinterestinterleukin-22novelperipheral bloodreceptorresponsestatisticstranscriptomics
项目摘要
Ocular inflammatory diseases, including uveitis and AMD, cause significant visual loss. Using a variety of immune techniques we have evaluated various characteristics of immune cells in these diseases, including signaling pathways, e.g. inflammatory and autoimmune pathway. We have seen varying molecular signatures for uveitis. Of particular interest is the identification of IL-22. The expression of IL-22 has been recently associated with Th17 cells which is elevated in the serum of AMD and uveitis patients. We have shown that IL-22 resulted in apoptosis in cultured primary RPE cells, possibly by decreasing the phosphorylated-Bad level. In addition, we saw increased IL-17 activity in the immune cells of patients with age related macular degeneration.
We have reported epigenetic alterations the immune cells of AMD patients but this remains to be verified. However, an increase in the presence of immune markers such as IL-17 and its receptor in the eyes of AMD were noted, whatever their mechanism may be. In addition, patients with steroid refractory uveitis have a characteristic subpopulation of steroid refractory CD4+ T cells in their peripheral blood. Previously studies have demonstrated that this steroid refractory phenotype is restricted to the central memory pool of CD4+ cells which have the capacity to generate IL-17. We therefore compared transcriptomic responses of Th1 and Th17 cells to corticosteroids in order to identify novel biomarkers and targets for therapeutic intervention in steroid refractory disease. Steroid refractory patients have a greater propensity than sensitive patients to generate Th17 cells, but Th17 cells from either group of patients have a similarly restricted change in gene expression following exposure to Dex compared with Th1 cells.
Using additional techniques we have identified that a subgroup of uveitis patients have markedly shortened telomere length. In addition we have noted circulating IL-17 in sarcoidosis patients which is associated with active disease. We have collaborated with the University of Maryland to look at new ways to identify disease phenotypes. One particularly interesting approach has been that of supercell statistics, a single cell based averaging procedure followed by a machine learning scheme.
包括葡萄膜炎和AMD在内的眼部炎症性疾病导致显著的视力丧失。使用各种免疫技术,我们已经评估了这些疾病中免疫细胞的各种特征,包括信号传导途径,例如炎症和自身免疫途径。 我们已经看到葡萄膜炎的不同分子特征。 特别感兴趣的是IL-22的鉴定。IL-22的表达最近与AMD和葡萄膜炎患者血清中升高的Th 17细胞相关。我们已经表明,IL-22导致培养的原代RPE细胞凋亡,可能是通过降低磷酸化Bad水平。 另外我们 在年龄相关性黄斑变性患者的免疫细胞中观察到IL-17活性增加。
我们已经报道了AMD患者免疫细胞的表观遗传改变,但这仍有待证实。然而,注意到AMD患者眼中免疫标记物如IL-17及其受体的存在增加,无论其机制如何。 此外,类固醇难治性葡萄膜炎患者在其外周血中具有类固醇难治性CD 4 + T细胞的特征性亚群。先前的研究已经证明,这种类固醇难治性表型仅限于具有产生IL-17能力的CD 4+细胞的中央记忆库。因此,我们比较了Th 1和Th 17细胞对皮质类固醇的转录组反应,以确定新的生物标志物和类固醇难治性疾病的治疗干预靶点。类固醇难治性患者比敏感性患者更倾向于产生Th 17细胞,但与Th 1细胞相比,来自任一组患者的Th 17细胞在暴露于Dex后的基因表达变化相似地受到限制。
使用额外的技术,我们已经确定,一个亚组的葡萄膜炎患者有显着缩短端粒长度。此外,我们注意到结节病患者的循环IL-17与活动性疾病相关。我们与马里兰州大学合作,寻找识别疾病表型的新方法。一个特别有趣的方法是超级细胞统计,一个基于单个细胞的平均过程,然后是机器学习方案。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Robert Nussenblatt其他文献
Robert Nussenblatt的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Robert Nussenblatt', 18)}}的其他基金
Multicenter uveitis trial using a steroid implant and inflammatory mediators
使用类固醇植入物和炎症介质的多中心葡萄膜炎试验
- 批准号:
8556837 - 财政年份:
- 资助金额:
$ 23.03万 - 项目类别:
A Randomized Study of the Effect of Tai Chi Chuan Compared to Exercise
太极拳与运动效果比较的随机研究
- 批准号:
7964984 - 财政年份:
- 资助金额:
$ 23.03万 - 项目类别:
Multicenter uveitis trial using a steroid implant and inflammatory mediators
使用类固醇植入物和炎症介质的多中心葡萄膜炎试验
- 批准号:
8737638 - 财政年份:
- 资助金额:
$ 23.03万 - 项目类别:
ORAL ADMINISTRATION OF ANTIGEN AND THE OCULAR IMMUNE RESPONSE
口服抗原和眼部免疫反应
- 批准号:
8339751 - 财政年份:
- 资助金额:
$ 23.03万 - 项目类别:
Treatment of choroidal subretinal neovascularization with immune agents
免疫制剂治疗脉络膜视网膜下新生血管
- 批准号:
8339779 - 财政年份:
- 资助金额:
$ 23.03万 - 项目类别:
Treatment of choroidal subretinal neovascularization with immune agents
免疫制剂治疗脉络膜视网膜下新生血管
- 批准号:
8149176 - 财政年份:
- 资助金额:
$ 23.03万 - 项目类别:
相似海外基金
I(eye)-SCREEN: A real-world AI-based infrastructure for screening and prediction of progression in age-related macular degeneration (AMD) providing accessible shared care
I(eye)-SCREEN:基于人工智能的现实基础设施,用于筛查和预测年龄相关性黄斑变性 (AMD) 的进展,提供可及的共享护理
- 批准号:
10102692 - 财政年份:2024
- 资助金额:
$ 23.03万 - 项目类别:
EU-Funded
Inhibiting Neovascularization and Subretinal Fibrosis in Neovascular Age-Related Macular Degeneration
抑制新生血管性年龄相关性黄斑变性的新生血管形成和视网膜下纤维化
- 批准号:
10639785 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Inhibition of melanogenesis in retinal pigment epithelium, a contributing factor in age-related macular degeneration
抑制视网膜色素上皮中的黑色素生成,这是年龄相关性黄斑变性的一个促成因素
- 批准号:
23K09052 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Evaluation of New Anti-inflammatory Treatments for Age-Related Macular Degeneration
年龄相关性黄斑变性的新型抗炎治疗方法的评价
- 批准号:
10642988 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Progression of Early Atrophic Lesions in Age-related Macular degeneration
年龄相关性黄斑变性早期萎缩性病变的进展
- 批准号:
10635325 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Cellular and molecular mechanisms of AIM2 and NLRP3 inflammasome activation in age-related macular degeneration
年龄相关性黄斑变性中 AIM2 和 NLRP3 炎症小体激活的细胞和分子机制
- 批准号:
10584110 - 财政年份:2023
- 资助金额:
$ 23.03万 - 项目类别:
Elucidation of roles of mast cells and macrophages in the pathogenesis of age-related macular degeneration
阐明肥大细胞和巨噬细胞在年龄相关性黄斑变性发病机制中的作用
- 批准号:
22H03243 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
AMD Mitochondria Modulate Expression of microRNA 135b-5p and 148a-3p in RPE Cybrids: Implications for Age-related Macular Degeneration
AMD 线粒体调节 RPE Cybrids 中 microRNA 135b-5p 和 148a-3p 的表达:对年龄相关性黄斑变性的影响
- 批准号:
10433610 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别:
Targeting the inflammatory response in age-related macular degeneration
针对年龄相关性黄斑变性的炎症反应
- 批准号:
10504138 - 财政年份:2022
- 资助金额:
$ 23.03万 - 项目类别: